Fulgent Genetics is a diagnostics company offering genetic and molecular testing services, including inherited-disease, oncology, and infectious-disease testing, and is developing therapeutic drug candidates.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 76 | New buy | 211,708 | $4,344,248 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Added +28% | 81,727 | $1,677,038 | 0.0% |
| Louis Bacon / Moore | 53 | Added +5% | 48,343 | $991,998 | 0.0% |
| Ancora | 40 | Holds (flat) | 500 | $10,260 | 0.0% |
| Filed | Form | Activist | % of class | Conviction | |
|---|---|---|---|---|---|
| 2026-03-31 | SCHEDULE 13D/A | Hsieh Ming | 30.7% | Med | filing |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.